This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ryffel, K.
Right arrow Articles by Dayer, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ryffel, K.
Right arrow Articles by Dayer, E.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, December 1999, p. 4086-4092, Vol. 37, No. 12
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Scored Antibody Reactivity Determined by Immunoblotting Shows an Association between Clinical Manifestations and Presence of Borrelia burgdorferi sensu stricto, B. garinii, B. afzelii, and B. Valaisiana in Humans

Karine Ryffel,1 Olivier Péter,1,* Bernard Rutti,2 André Suard,3 and Eric Dayer1

Maladies Infectieuses et Immunologie, Institut Central des Hôpitaux Valaisans, 1950 Sion-CH,1 Institut de Zoologie, Université de Neuchâtel, 2007 Neuchâtel-CH,2 and Rue du Bourg 1, 1870 Monthey,3 Switzerland

Received 1 March 1999/Returned for modification 3 May 1999/Accepted 16 August 1999

An immunoglobulin G immunoblot was developed with antigenic extracts of Borrelia burgdorferi sensu stricto, B. garinii, B. afzelii, and B. valaisiana genospecies and was reacted with sera from patients with neuroborreliosis, acrodermatitis, and Lyme arthritis. A detailed analysis of the reactivities of the protein bands was performed, and a two-step scoring procedure was selected to determine the preferential reactivity of sera to one particular genospecies. The discriminative potential of 5 proteins (12-kDa, 16-kDa, 18-kDa, OspA, and 66-kDa proteins) was used as a rapid first-step scoring method, followed by scoring of 14 additional protein bands if necessary. The advantage of this procedure is the low percentage of serum samples with inconclusive results for one of the four species (10% for patients with neuroborreliosis, 6% for patients with acrodermatitis chronica atrophicans, and 6% for patients with Lyme arthritis). Among 31 serum samples from patients with neuroborreliosis, 16 were more reactive to B. garinii, 7 were more reactive to B. afzelii, 3 were more reactive to B. valaisiana, and 2 were more reactive to B. burgdorferi sensu stricto. Of 31 serum samples from patients with acrodermatitis, 26 showed a higher level of reactivity to B. afzelii. Of 34 serum samples from patients with Lyme arthritis, 21 were more reactive to B. burgdorferi sensu stricto, 10 were more reactive to B. afzelii, and 1 was more reactive to B. valaisiana. Our results suggest an organotropism of Borrelia species and provide some evidence of a pathogenic potential of B. valaisiana in humans.


* Corresponding author. Mailing address: Maladies Infectieuses et Immunologie, Institut Central des Hôpitaux Valaisans, Av. Grand-Champsec, CH-1950 Sion, Switzerland. Phone: 41 27 603 47 90. Fax: 41 27 603 48 93. E-mail: olivier.peter{at}ichv.vsnet.ch.


Journal of Clinical Microbiology, December 1999, p. 4086-4092, Vol. 37, No. 12
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Kraiczy, P., Seling, A., Brissette, C. A., Rossmann, E., Hunfeld, K.-P., Bykowski, T., Burns, L. H., Troese, M. J., Cooley, A. E., Miller, J. C., Brade, V., Wallich, R., Casjens, S., Stevenson, B. (2008). Borrelia burgdorferi Complement Regulator-Acquiring Surface Protein 2 (CspZ) as a Serological Marker of Human Lyme Disease. CVI 15: 484-491 [Abstract] [Full Text]  
  • Younsi, H., Sarih, M., Jouda, F., Godfroid, E., Gern, L., Bouattour, A., Baranton, G., Postic, D. (2005). Characterization of Borrelia lusitaniae Isolates Collected in Tunisia and Morocco. J. Clin. Microbiol. 43: 1587-1593 [Abstract] [Full Text]  
  • Godfroid, E., Min Hu, C., Humair, P.-F., Bollen, A., Gern, L. (2003). PCR-Reverse Line Blot Typing Method Underscores the Genomic Heterogeneity of Borrelia valaisiana Species and Suggests Its Potential Involvement in Lyme Disease. J. Clin. Microbiol. 41: 3690-3698 [Abstract] [Full Text]  
  • Ornstein, K., Ostberg, Y., Bunikis, J., Noppa, L., Berglund, J., Norrby, R., Bergstrom, S. (2002). Differential Immune Response to the Variable Surface Loop Antigen of P66 of Borrelia burgdorferi Sensu Lato Species in Geographically Diverse Populations of Lyme Borreliosis Patients. CVI 9: 1382-1384 [Abstract] [Full Text]  
  • Panelius, J., Lahdenne, P., Saxen, H., Heikkila, T., Seppala, I. (2001). Recombinant Flagellin A Proteins from Borrelia burgdorferi Sensu Stricto, B. afzelii, and B. garinii in Serodiagnosis of Lyme Borreliosis. J. Clin. Microbiol. 39: 4013-4019 [Abstract] [Full Text]  
  • Lin, T., Oliver, J. H. Jr., Gao, L., Kollars, T. M. Jr., Clark, K. L. (2001). Genetic Heterogeneity of Borrelia burgdorferi Sensu Lato in the Southern United States Based on Restriction Fragment Length Polymorphism and Sequence Analysis. J. Clin. Microbiol. 39: 2500-2507 [Abstract] [Full Text]  
  • Bretz, A. G., Ryffel, K., Hutter, P., Dayer, E., Peter, O. (2001). Specificities and Sensitivities of Four Monoclonal Antibodies for Typing of Borrelia burgdorferi Sensu Lato Isolates. CVI 8: 376-384 [Abstract] [Full Text]  
  • Escudero, R., Barral, M., Pérez, A., Vitutia, M. M., García-Pérez, A. L., Jiménez, S., Sellek, R. E., Anda, P. (2000). Molecular and Pathogenic Characterization of Borrelia burgdorferi Sensu Lato Isolates from Spain. J. Clin. Microbiol. 38: 4026-4033 [Abstract] [Full Text]